Clinical Trials On Bio
-
Laboratory Data Management Program Boosts Productivity Scores Big On Customer Satisfaction
6/21/2013
A major biotechnology firm asked INC Research/inVentiv Health to help reengineer laboratory data management activities to enhance productivity.
-
Estimating The Budget Impact Of A New Pain Treatment
6/21/2013
Opioids are used to treat both acute and chronic pain; however, traditional μ-opioids are often associated with opioid-induced side effects that can limit treatment effectiveness. Issues with tolerability have led to the development of novel opioids that may have a more favorable adverse event profile.
-
Evolution Of An Outsourced Monitoring Model
6/21/2013
One of the world‟s largest pharmaceutical companies chose to outsource their clinical monitoring function completely.
-
Corrective Action Road Map Enhances Client Readiness For Regulatory Expectations
6/21/2013
A large healthcare company specializing in pharmaceuticals and medical devices identified a high priority need for independent monitors to conduct due diligence visits at investigator sites.
-
Remote Monitoring Solution Improves Compliance
6/21/2013
One of the world’s largest pharmaceutical companies had instituted an obligation for its monitors to review clinical data within 15 calendar days of it being entered into the database, but through December 2011, compliance had been just 78%.
-
H1N1 Vaccine Program
6/21/2013
Seamless teamwork among INC Research/inVentiv Health, sponsor and sites results in multinational studies with zero audit findings.
-
How A Leading Sponsor’s Metrics Were Exceeded For Global Vaccine Enrollment And DB Lock
6/21/2013
A leading pharmaceutical company contracted with INC Research/inVentiv Health Clinical to conduct a large global vaccine study involving more than 900 elderly subjects, all of whom were 68 years of age or older, at more than 50 study sites.
-
Achieving Substantial Savings Through A InVentiv Health Sourcing Partnership
6/21/2013
An international biopharmaceutical company (and existing client) was looking to improve the way it managed data from its clinical trials and wanted to consolidate its clinical data management activities.
-
Bridging Studies For 505(b)(2) Approval
6/21/2013
The sponsor required assistance with a 505(b)(2) application for a well established compound where a different salt of the active ingredient has been proposed.
-
To The Rescue – Getting A Phase I Oncology Study Back On Track
6/21/2013
A small, oncology-focused biotech was experiencing significant data, safety, vendor and monitoring issues in its Phase I programs that were worsening with time.